系统性硬化症相关间质性肺病自体造血干细胞移植后胸部高分辨率CT的变化
本研究在33例连续性弥漫性系统性硬化症患者中,于自体造血干细胞移植前后每年 routine 随访时评估胸部高分辨率CT、肺功能及皮肤评分,由两名放射科医生盲法采用Goh和Wells半定量法评估间质性肺病范围、最宽食管直径和食管体积。移植后12个月和24个月间质性肺病范围及磨玻璃影回归显著,18例分类为放射学应答者(应答概率0.78,95%CI 0.58,0.90),但食管扩张加重;放射学应答者5年生存率有优于非应答者的趋势(100% vs 60%;HR 0.23,95%CI 0.03,1.62,P=0.11)。
要点
- 移植后12个月和24个月间质性肺病范围及磨玻璃影较移植前显著改善。
- 18例(应答概率0.78,95%CI 0.58,0.90)分类为放射学应答者。
- 食管扩张在移植后12个月和24个月显著加重,需特别关注。
核心结论
- 真实世界数据分析证实自体造血干细胞移植后24个月高分辨率CT所示系统性硬化症相关间质性肺病范围显著改善,但食管扩张加重需特别关注。
研究设计与样本
- 研究纳入2000年1月至2016年9月间33例连续性弥漫性系统性硬化症患者,在自体造血干细胞移植前后每年 routine 随访时评估胸部高分辨率CT、肺功能和皮肤评分变化。
- 由两名独立放射科医生盲法采用Goh和Wells半定量法评估间质性肺病范围、最宽食管直径和食管体积。
- 根据移植后24个月时高分辨率CT间质性肺病达到稳定或减少5%及以上,将患者回顾性分类为放射学应答者或非应答者。
主要发现
- 线性混合模型显示,移植后12个月间质性肺病范围回归显著(P=0.001),磨玻璃影回归显著(P=0.0001);移植后24个月间质性肺病范围回归显著(P=0.007),磨玻璃影回归显著(P=0.0008)。
- 18例患者分类为放射学应答者,应答概率0.78(95%CI 0.58,0.90)。
- 移植后12个月最宽食管直径显著增加(P=0.03),食管体积P=0.34;移植后24个月最宽食管直径显著增加(P=0.002),食管体积显著增加(P=0.007)。
- Kaplan-Meier分析显示,移植后24个月随访时放射学应答者与非应答者相比,5年生存率有更好趋势(100% vs 60%;HR 0.23,95%CI 0.03,1.62,P=0.11)。
关键数值与推荐
- 放射学应答定义为移植后24个月时高分辨率CT间质性肺病达到稳定或减少5%及以上。
- 间质性肺病范围采用Goh和Wells半定量法评估。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate extent of interstitial lung disease (ILD) and oesophageal involvement using high-resolution computed tomography (HRCT) in early diffuse SSc patients after autologous haematopoietic stem cell transplantation (aHSCT). METHODS: Overall chest HRCT, lung function and skin score changes were evaluated in 33 consecutive diffuse SSc patients before and after aHSCT during yearly routine follow-up visits between January 2000 and September 2016. Two independent radiologists blindly assessed the ILD extent using semi-quantitative Goh and Wells method, the widest oesophageal diameter (WOD) and the oesophageal volume (OV) on HRCT. Patients were retrospectively classified as radiological responders or non-responders, based on achieved stability or a decrease of 5% or more of HRCT-ILD at 24 months post-aHSCT. RESULTS: Using a linear mixed model, the regressions of the extent of ILD and of ground glass opacities were significant at 12 months (ILD P = 0.001; ground glass opacities P = 0.0001) and at 24 months (ILD P = 0.007; ground glass opacities P = 0.0008) after aHSCT, with 18 patients classified as radiological responders (probability of response 0.78 [95% CI 0.58, 0.90]). Meanwhile the WOD and the OV increased significantly at 12 months (WOD P = 0.03; OV P = 0.34) and at 24 months (WOD P = 0.002; OV P = 0.007). Kaplan-Meier analyses showed a trend towards better 5-year survival rates (100% vs 60%; hazard ratio 0.23 [95% CI 0.03, 1.62], P = 0.11) among radiological responders vs non-responders at 24 month follow-up after aHSCT. CONCLUSION: Real-world data analysis confirmed significant improvement in extent of HRCT SSc-ILD 24 months after aHSCT, although oesophageal dilatation worsened requiring specific attention.
引用
- Pugnet G, Petermann A, Collot S, et al. Changes on chest HRCT in systemic sclerosis-related interstitial lung disease after autologous haematopoietic stem cell transplantation. Rheumatology (Oxford). 2023. PMID: 35686921. doi:10.1093/rheumatology/keac319
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。